For research use only. Not for therapeutic Use.
Nemorexant (ACT-541468) is a potent orexin receptor antagonist extracted from patent WO2015083094A1, compound example 7, has IC50s of 2 nM and 3 nM for Ox1 receptor and Ox2 receptor, respectively.<br>Nemorexant (Compound example 7) is a orexin receptor antagonist with IC50s of 2 nM and 3 nM for Ox1 receptor and Ox2 receptor, respectively.
Catalog Number | I048023 |
CAS Number | 1505484-82-1 |
Synonyms | Daridorexant |
Molecular Formula | C23H23ClN6O2 |
Purity | 99% |
Target | HCRTR |
Target Protein | |
Appearance | Solid |
IC50 | IC50:2 nM(Ox1 receptor) and 3 nM(Ox2 receptor) |
IUPAC Name | [(2S)-2-(5-chloro-4-methyl-1H-benzimidazol-2-yl)-2-methylpyrrolidin-1-yl]-[5-methoxy-2-(triazol-2-yl)phenyl]methanone |
InChI | InChI=1S/C23H23ClN6O2/c1-14-17(24)6-7-18-20(14)28-22(27-18)23(2)9-4-12-29(23)21(31)16-13-15(32-3)5-8-19(16)30-25-10-11-26-30/h5-8,10-11,13H,4,9,12H2,1-3H3,(H,27,28)/t23-/m0/s1 |
InChIKey | NBGABHGMJVIVBW-QHCPKHFHSA-N |
SMILES | CC1=C(C=CC2=C1N=C(N2)C3(CCCN3C(=O)C4=C(C=CC(=C4)OC)N5N=CC=N5)C)Cl |